Therefore, more clinical trials utilizing a large generalizable T2DM patient population with less influence from baseline characteristics and longer follow-up durations are needed to help guide clinical decision-making and reduce the burden of T2DM while also promoting cardiovascular health
Who Can Receive Weight Loss Medications Branded FDA-approved weight loss medications are typically recommended for adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, hypertension, or high cholesterol
Talking to Your GP or Prescriber About Side Effects All gastrointestinal side effects should be reported to your trial team or GP
Gut (1996) 38:9169
Understanding Semaglutide and Its Mechanism Semaglutide is an FDA-approved GLP-1 receptor agonist prescribed for chronic weight management in adults with obesity or those overweight with weight-related conditions
In addition, insulin was delivered via the hollow microneedles into the dermis layer, which may not be adsorbed efficiently enough and stay around the microneedle